Discontinuation rates were substantially reduced to 18.8% (95% CI 18.6, 19.0) at 1 year and 36.8% (95% CI 36.5, 37.1) at 3 years when using a grace period of 180 days, and to 28.8% (95% CI 28.5, 29.1) at 3 years when using a grace period of 365 days
Although not approved for human consumption, KLOW marks an exciting time in the continued investment and development of peptide therapy as a future treatment
Practical rule: Prefer vendors with repeatable results across several tests, not vendors with one impressive COA
Glutathione IV therapy is generally considered safe with minimal side effects
Mitochondrial Energy and Fat Oxidation: The Carnitine Connection Carnitine is a cofactor required to transport long-chain fatty acids across the inner mitochondrial membrane, where they are burned for energy
doi:10.1161/CIRCULATIONAHA.124.071689 34